Impact of Nursing-Lab Collaboration on Blood Transfusion Safety
DOI:
https://doi.org/10.22399/ijcesen.4148Keywords:
blood transfusion safety, Nursing-lab collaboration, healthcare teamwork, patient outcomesAbstract
The collaborative efforts between nursing staff and laboratory professionals play a crucial role in enhancing blood transfusion safety within healthcare settings. Effective communication and teamwork between these two groups are essential for ensuring the accurate identification of patient blood types and the timely administration of transfusions. By establishing clear protocols and regular training sessions, nursing-lab collaboration can minimize the risk of transfusion-related errors, such as mismatches or delays in receiving the correct blood products. Research has shown that fostering a culture of collaboration not only improves patient outcomes but also enhances the overall efficiency of the transfusion process, ultimately leading to a safer healthcare environment. Evaluating the impact of nursing-lab collaboration on blood transfusion safety involves analyzing key metrics such as incident rates, patient outcomes, and staff satisfaction levels. Implementing a systematic approach to monitor these metrics can help identify areas for improvement and best practices that contribute to transfusion safety. Furthermore, involving nurses in the development of laboratory policies can foster a sense of ownership and responsibility, leading to more conscientious adherence to safety protocols. As healthcare systems increasingly recognize the importance of interdisciplinary collaboration, ongoing assessments of nursing-lab partnerships will be vital to enhancing transfusion safety and promoting high-quality care.
References
1. Koch C. G., Li L., Sun Z., Hixson E. D., Tang A., Phillips S. C., Blackstone E. H., Henderson J. M. (2013). Hospital‐acquired anemia: Prevalence, outcomes, and healthcare implications. Journal of Hospital Medicine, 8(9), 506–512. 10.1002/jhm.2061
2. Harm S. K., Yazer M. H., Monis G. F., Triulzi D. J., AuBuchon J. P., Delaney M. (2014). A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease. American Journal of Clinical Pathology, 141(2), 256–261. 10.1309/AJCP47QAAXTOZEKJ
3. Curley G. F., Shehata N., Mazer C. D., Hare G. M., Friedrich J. O. (2014). Transfusion triggers for guiding RBC transfusion for cardiovascular surgery: A systematic review and meta-analysis*. Critical Care Medicine, 42(12), 2611–2624. 10.1097/CCM.0000000000000548
4. Sharma S., Sharma P., Tyler L. N. (2011). Transfusion of blood and blood products: Indications and complications. American Family Physician, 83(6), 719–724.
5. Rhee P., Inaba K., Pandit V., Khalil M., Siboni S., Vercruysse G., Kulvatunyou N., Tang A., Asif A., O’Keeffe T., Joseph B. (2015). Early autologous fresh whole blood transfusion leads to less allogeneic transfusions and is safe. Journal of Trauma and Acute Care Surgery, 78(4), 729–734. 10.1097/TA.0000000000000599
6. Davies A., Staves J., Kay J., Casbard A., Murphy M. F. (2006). End‐to‐end electronic control of the hospital transfusion process to increase the safety of blood transfusion: Strengths and weaknesses. Transfusion, 46(3), 352–364. 10.1111/j.1537-2995.2006.00729.x
7. Piccin A., Spizzo G., Popovski M. A., Russo F. P., Armanaschi L., Vecchiato C., Frena A., Mega A. (2021). Transfusion-associated circulatory overload in gastroenterology. Blood Transfusion, 19(3), 197–204. 10.2450/2020.0025-20
8. Moher D., Liberati A., Tetzlaff J., Altman D. G., & PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLOS Medicine, 6(7), e1000097. 10.1371/journal.pmed.1000097
9. Bagwe S., Chung L. K., Lagman C., Voth B. L., Barnette N. E., Elhajjmoussa L., Yang I. (2017). Blood transfusion indications in neurosurgical patients: A systematic review. Clinical Neurology and Neurosurgery, 155, 83–89. 10.1016/j.clineuro.2017.02.006
10. Tsai S. F., Tarng D. C. (2019). Anemia in patients of diabetic kidney disease. Journal of the Chinese Medical Association , 82(10), 752–755. 10.1097/JCMA.0000000000000175
11. Park H. D., Kim H. K., Kim J. W., Kim D. W., Lee J. H., Huh W., Youn J. I., Kim H. G., Kim Y. G., Kim M. H., Lee S. Y. (2008). Evaluation of the transfusion safety of blood products and determination of plasma concentrations of acitretin and etretinate in patients receiving transfusions. Transfusion, 48(11), 2395–2400. 10.1111/j.1537-2995.2008.01850.x
12. Ugwu A., Gwarzo D., Nwagha T., Gwarzo A., Greinacher A. (2020). Transfusion in limited infrastructure locations–where to go decades after safe blood initiative by World Health Organization? ISBT Science Series, 15(1), 118–125. 10.1111/voxs.12519
13. Pirenne F., Yazdanbakhsh K. (2018). How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions. Blood, 131(25), 2773–2781. 10.1182/blood-2018-02-785964
14. Sharif M., Saxena A., Singh S., Manchala S., Jafri N. (2020). Blood component transfusion in a tertiary Care Hospital. Indian Journal of Pediatrics, 87(5), 339–344. 10.1007/s12098-020-03186-2
15. Body S. C., Birmingham J., Parks R., Ley C., Maddi R., Shernan S. K., Siegel L. C., Stover E. P., D’Ambra M. N., Levin J., Mangano D. T., Spiess B. D. (1999). Safety and efficacy of shed mediastinal blood transfusion after cardiac surgery: A multicenter observational study. Multicenter Study of Perioperative Ischemia Research Group. Journal of Cardiothoracic and Vascular Anesthesia, 13(4), 410–416. 10.1016/s1053-0770(99)90212-4
16. Desjardins P., Turgeon A. F., Tremblay M.-H., Lauzier F., Zarychanski R., Boutin A., Moore L., McIntyre L. A., English S. W., Rigamonti A., Lacroix J. (2012). Hemoglobin levels and transfusions in neurocritically ill patients: A systematic review of comparative studies. Critical Care, 16(2), 1–11. 10.1186/cc11293
17. Miller K., Akers C., Magrin G., Whitehead S., Davis A. K. (2013). Piloting the use of 2D barcode and patient safety‐software in an Australian tertiary hospital setting. Vox Sanguinis, 105(2), 159–166. 10.1111/vox.12034
18. Hassall O. W., Thitiri J., Fegan G., Hamid F., Mwarumba S., Denje D., Wambua K., Mandaliya K., Maitland K., Bates I. (2015). Safety and efficacy of allogeneic umbilical cord red blood cell transfusion for children with severe anaemia in a Kenyan hospital: An open-label single-arm trial. Lancet. Haematology, 2(3), e101–e107. 10.1016/S2352-3026(15)00005-8
19. Jahr J. S., Mackenzie C., Pearce L. B., Pitman A., Greenburg A. G. (2008). HBOC-201 as an alternative to blood transfusion: Efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery. Journal of Trauma, 64(6), 1484–1497. 10.1097/TA.0b013e318173a93f
20. Malkin M., Nevo A., Brundage S. I., Schreiber M. (2021). Effectiveness and safety of whole blood compared to balanced blood components in resuscitation of hemorrhaging trauma patients-A systematic review. Injury, 52(2), 182–188. 10.1016/j.injury.2020.10.095
21. Machado A. A. V., Negrão F. J., Croda J., de Medeiros E. S., Pires M. A. D. S. (2019). Safety and costs of blood transfusion practices in dengue cases in Brazil. PLoS One, 14(7), e0219287. 10.1371/journal.pone.0219287
22. Shamshirian A., Mohseni A. R., Pourfathollah A. A., Mehdipour S., Hosseini S., Ghorbanpour A., Azizi S. (2020). A review of blood usage and wastage in a tertiary heart center. Acta Clinica Belgica, 75(2), 96–103. 10.1080/17843286.2018.1555113
23. Auten J. D., Lunceford N. L., Horton J. L., Galarneau M. R., Galindo R. M., Shepps C. D., Zieber T. J., Dewing C. B. (2015). The safety of early fresh, whole blood transfusion among severely battle injured at US Marine Corps forward surgical care facilities in Afghanistan. Journal of Trauma and Acute Care Surgery, 79(5), 790–796. 10.1097/TA.0000000000000842
24. Vesga M. A., Azkárate M. (2021). Information systems for a blood transfusion regional network. ISBT Science Series, 16(3), 231–238. 10.1111/voxs.12630
25. Kashefi P., Rahmani A., Khalifesoltani M. (2018). Changes in the hemoglobin level after one unit of packed red blood cell transfusion in Intensive Care Unit patients. Journal of Research in Medical Sciences: the Official Journal of Isfahan University of Medical Sciences, 23, 85. 10.4103/jrms.JRMS_64_17
26. Higgins J. P., Thomas J., Chandler J., Cumpston M., Li T., Page M. J., Welch V. A. (2019). Cochrane handbook for systematic reviews of interventions. Chichester: John Wiley & Sons. 10.1002/14651858.ED000142
27. Moncharmont P., Quittançon E., Barday G., Benamara A., Alpes l. C. d. H. e. d. s. t. A. R. (2019). Adverse transfusion reactions in patients with aplastic anaemia or myelodysplastic syndromes. Vox Sanguinis, 114(4), 349–354. 10.1111/vox.12765
28. Uriz M. J., Antelo M. L., Zalba S., Ugalde N., Pena E., Corcoz A. (2011). Improved traceability and transfusion safety with a new portable computerised system in a hospital with intermediate transfusion activity. Blood Transfusion, 9(2), 172–181. 10.2450/2011.0044-10
29. de Gast-Bakker D. H., De Wilde R. B., Hazekamp M. G., Sojak V., Zwaginga J. J., Wolterbeek R., de Jonge E., Gesink-van der Veer B. J. (2013). Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: A randomized controlled trial. Intensive Care Medicine, 39(11), 2011–2019. 10.1007/s00134-013-3085-7
30. Azizi S., Tabary S. Z., Soleimani A. (2014). Prevalence of acute blood transfusion reactions in Mazandaran Heart Center, Sari, Iran, 2010–2012. Medical Archives, 68(2), 137–139. 10.5455/medarh.2014.68.137-139
31. Galli L., Bruschi F. (2020). New strategies for the control of infectious and parasitic diseases in blood donors: The impact of pathogen inactivation methods. EuroBiotech Journal, 4(2), 53–66. 10.2478/ebtj-2020-0007
32. Whitehurst J. M., Schroder J., Leonard D., Horvath M. M., Cozart H., Ferranti J. (2012). Towards the creation of a flexible classification scheme for voluntarily reported transfusion and laboratory safety events. Journal of Biomedical Semantics, 3(1), 4. 10.1186/2041-1480-3-4
33. Bennett S., Baker L. K., Martel G., Shorr R., Pawlik T. M., Tinmouth A., McIsaac D. I., Hébert P. C., Karanicolas P. J., McIntyre L., Turgeon A. F., Barkun J., Fergusson D. (2017). The impact of perioperative red blood cell transfusions in patients undergoing liver resection: A systematic review. HPB , 19(4), 321–330. 10.1016/j.hpb.2016.12.008
34. Amato M., Schennach H., Astl M., Chen C. Y., Lin J. S., Benjamin R. J., Nussbaumer W. (2017). Impact of platelet pathogen inactivation on blood component utilization and patient safety in a large Austrian Regional Medical Centre. Vox Sanguinis, 112(1), 47–55. 10.1111/vox.12456
35. Liu D. X., Liu J., Zhang F., Zhang Q. Y., Xie M., Zhu Z. Q. (2015). Randomized controlled study on safety and feasibility of transfusion trigger score of emergency operations. Chinese Medical Journal, 128(13), 1801–1808. 10.4103/0366-6999.159357
36. Deleon A. N., Uecker J. M., Stafford S. V., Ali S., Clark A., Brown C. V. R. (2016). Restrictive transfusion in geriatric trauma patients. American Surgeon, 82(1), 85–88. 10.1177/000313481608200129
37. Silvergleid A. J., Kleinman S., Tirmauer J. (2018). Leukoreduction to prevent complications of blood transfusion.
38. Delaney M., Wendel S., Bercovitz R. S., Cid J., Cohn C., Dunbar N. M., Apelseth T. O., Popovsky M., Stanworth S. J., Tinmouth A., Van De Watering L., Waters J. H., Yazer M., Ziman A., & Biomedical Excellence for Safer Transfusion (BEST) Collaborative (2016). Transfusion reactions: Prevention, diagnosis, and treatment. Lancet, 388(10061), 2825–2836. 10.1016/S0140-6736(15)01313-6
39. Raval J. S., Griggs J. R., Fleg A. (2020). Blood product transfusion in adults: Indications, adverse reactions, and modifications. American Family Physician, 102(1), 30–38.
40. McQuilten Z. K., Crighton G., Brunskill S., Morison J. K., Richter T. H., Waters N., Murphy M. F., Wood E. M. (2018). Optimal dose, timing and ratio of blood products in massive transfusion: Results from a systematic review. Transfusion Medicine Reviews, 32(1), 6–15. 10.1016/j.tmrv.2017.06.003
41. Bianchi M., Papacci P., Valentini C. G., Barbagallo O., Vento G., Teofili L. (2018). Umbilical cord blood as a source for red-blood-cell transfusion in neonatology: A systematic review. Vox Sanguinis, 113(8), 713–725. 10.1111/vox.12720
42. Bennardello F., Fidone C., Cabibbo S., Calabrese S., Garozzo G., Cassarino G., Antolino A., Tavolino G., Zisa N., Falla C., Drago G., Di Stefano G., Bonomo P. (2009). Use of an identification system based on biometric data for patients requiring transfusions guarantees transfusion safety and traceability. Blood Transfusion, 7(3), 193–203. 10.2450/2009.0067-08
43. Gupta A., Gupta C. (2016). Role of National Accreditation Board of Hospitals and Healthcare Providers (NABH) core indicators monitoring in quality and safety of blood transfusion. Asian Journal of Transfusion Science, 10(1), 37–41. 10.4103/0973-6247.175394
44. Rafii F, Jan Amiri M, Dehnad A, Haghani H. The Effect of Workshop and Multimedia Training Methods on Nurses’ Knowledge and Performance on Blood Transfusion. Journal of Client-Centered Nursing Care. 2016;2(4):223–30.
45. Hijji B, Parahoo K, Hussein MM, Barr O. Knowledge of blood transfusion among nurses. Journal of clinical nursing. 2013;22(17-18):2536–50.
46. Bolton-Maggs PH. Transfusion safety in 2012: main messages from the SHOT Annual Report for 2012. Transfusion medicine (Oxford, England) 2013;23(4):217–8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Computational and Experimental Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
